Evaluation of a Night Spectacle Correction Concerning an Improvement of Mesopic Vision Quality

October 16, 2018 updated by: Stephan Degle, University of Applied Sciences Jena

Reduced quality of vision and glare in twilight or night are frequently mentioned complaints within the optometric examination. A reason for these problems could be a myopic refractive shift in dark light conditions, commonly known as night myopia or twilight myopia.

The aim of this study was to investigate whether quality of vision in twilight or night could be improved by a spectacle correction optimized for mesopic light conditions. Moreover, objective refraction in large pupils measured by aberrometry was compared to subjective mesopic refraction.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

After obtaining informed consent, aberrometry was performed in a darkened room (0.1 lux). Subjective photopic refraction and visual acuity were measured before light was turned off and mesopic refraction was obtained after a dark adaptation period of five minutes. Finally, frames and lenses were fitted by a centration system. Lens grinding was executed centralized by a grinding workshop. In the course of this study, subjects were randomly assigned to wear two glasses double-masked in turn. One with photopic subjective refraction data and another with mesopic subjective refraction data. Both were worn for 14 ± 2 days each.

Follow Up 1:

After two weeks, participants were asked for their subjective experiences with the first correction by a visual analogue scale questionnaire. After the evaluation, glasses were changed.

Follow Up 2:

Two weeks later, subjective experiences were evaluated again. After visual analogue scale questionnaire, subjects were asked to compare the two glasses concerning quality of mesopic vision and subjective safety level during night driving.

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Augsburg, Bavaria, Germany
        • Degle Optometry
      • Klingenberg am Main, Bavaria, Germany, 63911
        • Hessler Optometry
    • TH
      • Jena, TH, Germany, 07745
        • University of applied sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Visual Acuity at least 0.8 (5/6)
  • Binocular Vision

Exclusion Criteria:

  • refraction more than sph +/- 6 D and cyl 2 D
  • Difference between habitual correction and actual refraction more than 0.5 D
  • Medication with an influence on visual system
  • Disease or eye disease with an effect on the visual system
  • pregnancy or other hormonal variances
  • influence of drugs
  • mental handicap

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Night Spectacle Correction
Refraction for this glasses was obtained at low luminance.
Active Comparator: Spectacle Correction for photopic light conditions
Refraction for this glasses was obtained at high luminance level.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Night Myopia
Time Frame: Baseline only

Value of refractive shift (SE) when changing luminance from a photopic to a mesopic level.

At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group.

Baseline only

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mesopic Visual Acuity Improvement
Time Frame: Baseline only

Difference of visual acuity (monocular and binocular) in a darkened room (0.1 lux) after a dark adaption period of 5 min. with photopic spectacle correction ("classic" refraction obtained in photopic light conditions) compared to mesopic spectacle correction (correction of night myopia)

Scale: logMAR visual acuity, using Landolt C optotypes.

At Baseline, participants were not separated into arms as the Randomization Process was carried out at a later time point after participants picked up study glasses. Therefore, data are presented for All Participants in one Arm/Group.

Baseline only
Subjective Vision Comfort in Dark Light Conditions
Time Frame: Test Period (4 weeks)

Evaluation of subjective perceived vision comfort with the study and control glasses.

Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

Question:

How would you evaluate vision comfort with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good)

Test Period (4 weeks)
Subjective Vision Sharpness in Dark Light Conditions
Time Frame: Test Period (4 weeks)

Evaluation of subjective perceived vision sharpness with the study and control glasses.

Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

Question:

How would you evaluate vision sharpness with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (insufficient) to 100 (very good)

Test Period (4 weeks)
Subjective Glare Sensitivity in Dark Light Conditions
Time Frame: Test Period (4 weeks)

Evaluation of subjective perceived glare sensitivity with the study and control glasses.

Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

Question:

How would you evaluate glare sensitivity with the tested glasses in dark light conditions? Answer: visual analogue scale slider from 0 (no glare) to 100 (strong glare)

Test Period (4 weeks)
Subjective Driving Safety in Dark Light Conditions
Time Frame: Test Period (4 weeks)

Evaluation of subjective perceived driving safety sense with the study and control glasses.

Both glasses (study and control glasses) were tested for two weeks each. After the two weeks test, each of the glasses was evaluated. For evaluation a visual analogue scale questionnaire (Scale 0 - 100) was used.

Question:

How would you evaluate driving safety sense when driving in twilight or night with the tested glasses? Answer: visual analogue scale slider from 0 (not safe) to 100 (very safe)

Test Period (4 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Stephan Degle, Prof., University of Applied Sciences Jena

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

November 14, 2016

First Submitted That Met QC Criteria

November 14, 2016

First Posted (Estimate)

November 16, 2016

Study Record Updates

Last Update Posted (Actual)

February 28, 2019

Last Update Submitted That Met QC Criteria

October 16, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myopia-Night Blindness

Clinical Trials on Spectacle/Glasses

3
Subscribe